Continuous research and patient monitoring will be essential in addressing these concerns, ensuring that Semaglutide remains a safe and effective option for eligible patients
This integrated approach aims to maximize weight loss success by providing both medicinal support and behavioral guidance
Hypoglycaemia is uncommon with GLP-1 monotherapy but can occur when combined with insulin or sulfonylureas
Strategies for managing nausea include eating smaller meals, avoiding fatty foods during peak effect periods, and using ginger supplements
Choosing between tirzepatide and semaglutide depends on various factors, including personal health conditions, weight loss goals, and how the body responds to each medication
This intricate physiological process is termed mitochondrial dynamics (Liesa et al., 2009